Latest Insider Transactions at Sotera Health CO (SHC)
This section provides a real-time view of insider transactions for Sotera Health CO (SHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sotera Health Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sotera Health Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2023
|
Sean Laurence Cunningham |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+27.43%
|
-
|
|
Mar 06
2023
|
Michael B. Petras Jr. Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
213,189
+26.72%
|
-
|
|
Mar 06
2023
|
Michael P Rutz President of Sterigenics |
BUY
Grant, award, or other acquisition
|
Direct |
28,425
+4.52%
|
-
|
|
Mar 02
2023
|
Michael P Rutz President of Sterigenics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,948
-0.51%
|
$50,116
$17.41 P/Share
|
|
Mar 02
2023
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,841
-5.07%
|
$337,297
$17.41 P/Share
|
|
Nov 20
2022
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
29,251
-6.96%
|
$175,506
$6.02 P/Share
|
|
Nov 20
2022
|
Michael P Rutz President of Sterigenics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,911
-0.33%
|
$11,466
$6.02 P/Share
|
|
Nov 07
2022
|
Alexander Dimitrief SVP, General Counsel and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
235,478
+50.0%
|
-
|
|
May 27
2022
|
David Donnini |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+29.17%
|
-
|
|
May 27
2022
|
Sean Laurence Cunningham |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+29.17%
|
-
|
|
May 27
2022
|
Vincent K Petrella |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+29.17%
|
-
|
|
May 27
2022
|
James Neary |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+29.17%
|
-
|
|
May 27
2022
|
David E. Wheadon |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+34.76%
|
-
|
|
May 27
2022
|
Stephanie Geveda Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+29.17%
|
-
|
|
May 27
2022
|
Constantine S Mihas |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+29.17%
|
-
|
|
May 27
2022
|
Ruoxi Chen |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+29.17%
|
-
|
|
May 27
2022
|
Ann R. Klee |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+12.18%
|
-
|
|
Mar 02
2022
|
Michael B. Petras Jr. Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
187,219
+30.8%
|
-
|
|
Mar 02
2022
|
Scott J. Leffler CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
37,443
+4.82%
|
-
|
|
Mar 02
2022
|
Michael P Rutz President of Sterigenics |
BUY
Grant, award, or other acquisition
|
Direct |
24,962
+4.15%
|
-
|
|
Mar 02
2022
|
Terry Hammons SVP, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
22,466
+41.82%
|
-
|
|
Nov 20
2021
|
Michael P Rutz President of Sterigenics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,911
-0.34%
|
$42,042
$22.54 P/Share
|
|
Nov 20
2021
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,517
-10.55%
|
$605,374
$22.54 P/Share
|
|
Nov 20
2021
|
Scott J. Leffler CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,894
-0.55%
|
$85,668
$22.54 P/Share
|
|
Nov 11
2021
|
Terry Hammons SVP, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
8,791
+50.0%
|
-
|
|
Aug 25
2021
|
Michael P Rutz President of Sterigenics |
SELL
Open market or private sale
|
Direct |
67,000
-10.79%
|
$1,675,000
$25.03 P/Share
|
|
May 28
2021
|
Ruoxi Chen |
BUY
Grant, award, or other acquisition
|
Direct |
9,336
+38.04%
|
-
|
|
May 28
2021
|
Sean Laurence Cunningham |
BUY
Grant, award, or other acquisition
|
Direct |
9,336
+38.04%
|
-
|
|
May 28
2021
|
David Donnini |
BUY
Grant, award, or other acquisition
|
Direct |
9,336
+38.04%
|
-
|
|
May 28
2021
|
Stephanie Geveda Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,336
+38.04%
|
-
|
|
May 28
2021
|
Ann R. Klee |
BUY
Grant, award, or other acquisition
|
Direct |
9,336
+12.37%
|
-
|
|
May 28
2021
|
Constantine S Mihas |
BUY
Grant, award, or other acquisition
|
Direct |
9,336
+38.04%
|
-
|
|
May 28
2021
|
James Neary |
BUY
Grant, award, or other acquisition
|
Direct |
9,336
+38.04%
|
-
|
|
May 28
2021
|
Vincent K Petrella |
BUY
Grant, award, or other acquisition
|
Direct |
9,336
+38.04%
|
-
|
|
May 28
2021
|
David E. Wheadon |
BUY
Grant, award, or other acquisition
|
Direct |
9,336
+50.0%
|
-
|
|
Mar 22
2021
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Open market or private sale
|
Indirect |
817,439
-11.36%
|
$21,253,414
$26.12 P/Share
|
|
Mar 22
2021
|
Matthew J Klaben SVP, GC and Secretary |
SELL
Open market or private sale
|
Indirect |
41,952
-11.36%
|
$1,090,752
$26.12 P/Share
|
|
Mar 22
2021
|
Gtcr Investment Xi LLC Director |
SELL
Open market or private sale
|
Indirect |
9,008,388
-11.36%
|
$234,218,088
$26.12 P/Share
|
|
Mar 22
2021
|
Warburg Pincus & Co. Director |
SELL
Open market or private sale
|
Indirect |
27,025,164
-11.36%
|
$702,654,264
$26.12 P/Share
|
|
Nov 24
2020
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,383,923
-55.81%
|
$29,062,383
$21.68 P/Share
|
|
Nov 24
2020
|
Matthew J Klaben SVP, GC and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
69,196
-15.78%
|
$1,453,116
$21.68 P/Share
|
|
Nov 24
2020
|
Scott J. Leffler CFO and Treasurer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
115,326
-14.06%
|
$2,421,846
$21.68 P/Share
|
|
Nov 20
2020
|
Ruoxi Chen |
BUY
Grant, award, or other acquisition
|
Direct |
5,869
+50.0%
|
-
|
|
Nov 20
2020
|
Ann R. Klee |
BUY
Grant, award, or other acquisition
|
Direct |
5,869
+9.37%
|
-
|
|
Nov 20
2020
|
Stephanie Geveda Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,869
+50.0%
|
-
|
|
Nov 20
2020
|
Michael P Rutz President of Sterigenics |
BUY
Grant, award, or other acquisition
|
Direct |
26,086
+4.03%
|
-
|
|
Nov 20
2020
|
Vincent K Petrella |
BUY
Grant, award, or other acquisition
|
Direct |
5,869
+50.0%
|
-
|
|
Nov 20
2020
|
David Donnini |
BUY
Grant, award, or other acquisition
|
Direct |
5,869
+50.0%
|
-
|
|
Nov 20
2020
|
James Neary |
BUY
Grant, award, or other acquisition
|
Direct |
5,869
+50.0%
|
-
|
|
Nov 20
2020
|
Michael B. Petras Jr. Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
260,869
+50.0%
|
-
|